Insuman Basal Vial
Information About Insuman Basal Vial
About Insuman Basal Vial
Medicine Brand INSUMAN BASAL VIAL is manufactured by AVENTIS and mainly contents the generic drug Intermediate Acting Human Insulin Protamine.
Pakaging
-
Active Ingredients For Insuman Basal Vial
Intermediate Acting Human Insulin Protamine 40 IU
Diseases List For Which Insuman Basal Vial Is Prescribed
This Drug Is Prescribed For Type 1 diabetes Mallitus
Other Significations For Insuman Basal Vial
This Medication Insulin is a naturallyoccurring hormone secreted by the pancreas Insulin is required by the cells of the body in order for them to remove and use glucose from the blood From glucose the cells produce the energy that they need to carry out their functions Researchers first gave an active extract of the pancreas containing insulin to a young diabetic patient in 1922 and the FDA first approved insulin in 1939 Currently insulin used for treatment is derived from beef and pork pancreas as well as recombinant human technology The first recombinant human insulin was approved by the FDA in 1982 Patients with diabetes mellitus have an inability to take up and use glucose from the blood and as a result the glucose level in the blood rises In type 1 diabetes the pancreas cannot produce enough insulin Therefore insulin therapy is needed In type 2 diabetes patients produce insulin but cells throughout the body do not respond normally to the insulin Nevertheless insulin also may be used in type 2 diabetes to overcome the resistance of the cells to insulin By increasing the uptake of glucose by cells and reducing the concentration of glucose in the blood insulin prevents or reduces the longterm complications of diabetes including damage to the blood vessels eyes kidneys and nerves Insulin is administered by injection under the skin subcutaneously The subcutaneous tissue of the abdomen is preferred because absorption of the insulin is more consistent from this location than subcutaneous tissues in other locations Regular rapid onset of action short duration of action and NPH slower onset of action longer duration of action human insulin are the most commonlyused preparations Regular insulin has an onset of action begins to reduce blood sugar within 30 minutes of injection reaches a peak effect at 13 hours and has effects that last 68 hours NPH insulin is an insulin with an intermediate duration of action It has an onset of action starting about 2 hours following injection It has a peak effect 412 hours after injection and a duration of action of 1826 hours Lente insulin also is an insulin with an intermediate duration of action It has an onset of action 24 hours after injection a peak activity 612 hours after injection and a duration of action of 18 to 26 hours Ultralente insulin is a longacting insulin with an onset of action 48 hours after injection a peak effect 1030 hours after injection and a duration of action of more than 36 hours An ultra rapidacting insulin insulin lispro is a chemicallymodified natural insulin It was approved by the FDA in June 1996 As compared to regular insulin insulin lispro has a more rapid onset of action an earlier peak effect and a shorter duration of action It reaches peak activity 0525 hours after injection Therefore insulin lispro should be injected 15 minutes before a meal as compared to regular insulin which is injected 3060 minutes before a meal Insulin aspart and insulin glargine are both human insulin that have had their chemical composition slightly altered The chemical changes provide insulin aspart with a faster onset of action 20 minutes and a shorter duration of action 35 hours than regular human insulin It reaches peak activity 13 hours after injection Insulin glargine has a slower onset of action 70 minutes and a longer duration of action 24 hours than regular human insulin Its activity does not peak
Precautions To Be Taken Before Insuman Basal Vial
Tell your doctor of all prescription and nonprescription medication you may use Do not start or stop any medicine without doctor or pharmacist approval
Major Conditions And Care
Pregnancy And Insuman Basal Vial
Can We Take Insuman Basal Vial During Pregnancy?
Pregnancy Class : C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Insuman Basal Vial
Can We Use Insuman Basal Vial During Lactation
Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective
Side Effects Of Insuman Basal Vial
Nausea stomach upset skin rash acute toxicity